NIH recommends range of adjuvant breast cancer therapies.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D017698:Postmenopause; D017410:Practice Guidelines as Topic; D017697:Premenopause; D011960:Receptors, Estrogen / Q000378:metabolism; D014481:United States
D000970:Antineoplastic Agents; D011960:Receptors, Estrogen